semaglutide alcohol use disorder GLP-1 medications: The next big thing in treatment? – Recovery Research Institute Semaglutide and Tirzepatide reduce alcohol

People taking retatrutide, a drug being developed by Eli Lilly, lost an average of more than 70 pounds, or 28.3% of their bodyweight, over the course of 80 weeks, according to the company's preliminary report of clinical trial results

Additionally, 66% of people who received the treatment lost at least 10% of their body weight, compared to just 12% of people given a placebo

Targeting oxidative stress for treatment of glaucoma and optic neuritis

This is a genuine pharmaceutical breakthrough

This leads to skin that feels thicker and more resilient, rather than thinner and more sensitive

The ad itself is direct and to the point, talking about a pain point the entire world is facing